ConceptMedicine
Onasemnogene abeparvovec-xioi (Zolgensma)
A gene replacement therapy utilizing an adeno-associated virus serotype 9 vector to deliver the SMN1 gene for the treatment of all types of spinal muscular atrophy in patients under two years of age.
Know first
Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.
Lecturers
1Connections
3The lectures that define it or assume it, and the concepts next to it.